新生儿发作负担在治疗前与对初始抗发作药物的反应之间的关系
Adam L Numis1, Hannah C Glass2, Bryan A Comstock3
1Department of Neurology and Weill Institute for Neuroscience, University of California San Francisco, San Francisco, CA; Department of Pediatrics UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, CA.
The Journal of pediatrics
|February 15, 2024
概括
患有缺氧缺血性脑病变 (HIE) 的新生儿的每小时最大发作负担预测了对抗药物 (ASM) 的反应. 较高的发作负担与成功治疗的机会较低有关.
科学领域:
- 新生儿神经病学 新生儿神经病学
- 神经生理学 神经生理学
- 临床神经药理学 临床神经药理学
背景情况:
- 低毒性缺血性脑病变 (HIE) 是新生儿脑损伤的主要原因.
- 在患有HIE的新生儿中,发作很常见,需要及时治疗.
- 预测抗发作药物 (ASM) 的反应对于有效的HIE管理至关重要.
研究的目的:
- 调查治疗前发作负担和总发作持续时间与新生儿HIE初始ASM治疗成功之间的关联.
- 确定最大每小时发作负担是否比总发作持续时间更好地预测ASM反应.
主要方法:
- 从HEAL试验中对中度至重度HIE和急性症状发作的新生儿进行了回顾性审查.
- 持续的脑电图 (EEG) 监测以量化的负担和持续时间.
- 普森回归分析,以评估发作参数与成功的ASM初始反应之间的关联.
主要成果:
- 较高的治疗前最大每小时发作负担与成功的初始ASM反应的可能性较低有关 (每5分钟增加的aRR为0.83).
- 在治疗前的总发作时间和成功的ASM反应之间没有发现显著的关联.
- 矛盾的是,较短的治疗时间与成功反应的几率略低有关.
结论:
- 每小时最大的发作负担是初始ASM治疗成功的重要预测因子,在新生儿与HIE.
- 这一指标在临床上可能比总发作持续时间更重要,以指导急性发作管理.
- 进一步的研究是有必要的,以优化基于扣押负担特征的ASM选择.
相关概念视频
01:24Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
301
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
301
01:13Seizures: Classification
349
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
349
01:08Antiepileptic Drugs: Sodium Channel Blockers
559
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
559
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399